Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Your search for ���������������������������������������������:kn39��� returned no results
Showing 721 to 728 of 728 results for ���������������������������������������������:know���

  1. Avelumab not recommended as a maintenance treatment of urothelial cancer

    NICE has issued draft guidance which does not recommend avelumab for maintenance treatment of urothelial cancer after platinum-based chemotherapy.

  2. NICE and NIHR: working together to produce research with impact

    Alice and Zoe discuss how the National Institute of Health Research (NIHR) and NICE work in partnership and identify key research priorities from NICE guidance.

  3. Dr Samantha Roberts starts work as NICE CEO today

    Dr Roberts, who is a qualified doctor, has 20 years’ experience in clinical and management posts in healthcare both in the private and public sector.

  4. 14,000 women at risk of fractures after the menopause to benefit from bone disease drug

    Over 14,000 people to benefit after NICE published final guidance recommending abaloparatide as an option for treating osteoporosis after menopause, if there is a very high risk of fracture.

  5. NICE recommends treatment options for severe pregnancy sickness

    Nausea and vomiting, often referred to as morning sickness, is common in pregnancy. Close to 80% of pregnant women experience these symptom.

  6. Shared decision making recommendations will ensure people are at the heart of healthcare

    NICE’s new guideline on shared decision making will help transform people’s experiences of health and social care.

  7. Correctly gather information on people's alcohol drinking habits to ensure those who need help are not missed, says NICE

    Thousands of people asked each year could be missing out on brief interventions to help curb problem drinking, or a potential referral to specialist alcohol services.

  8. NICE recommends better targeting of antibiotics for suspected sepsis

    Our guidance recommends better targeting of antibiotics to those at the highest risk of suspected sepsis to ensure the right people receive treatment.